
Invacare Corporation IVC
Quarterly report 2023-Q1
added 05-15-2023
Invacare Corporation DPO Ratio 2011-2026 | IVC
Annual DPO Ratio Invacare Corporation
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 75.6 | 62.1 | 52.3 | 48.2 | 47.9 | 47.4 | 42.2 | 46.5 | 47.5 | 43.7 | 48.1 | 45.8 |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 75.6 | 42.2 | 50.6 |
Quarterly DPO Ratio Invacare Corporation
| 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 66.5 | - | 68.1 | 75.3 | 74.8 | - | 61.4 | 56.2 | 57.5 | - | 57.4 | 62.4 | 26.8 | - | 47.8 | 47 | 50.8 | - | 47.1 | 47.2 | 49 | - | 45.9 | 49 | 49 | - | 41.4 | 40 | 46.1 | - | 46.3 | 46.1 | 48.5 | - | 46.4 | 46.5 | 48.7 | - | 43.9 | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 75.3 | 26.8 | 51.5 |
DPO Ratio of other stocks in the Medical devices industry
| Issuer | DPO Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Aziyo Biologics
AZYO
|
48.8 | - | 1.37 % | $ 20.5 M | ||
|
Bruker Corporation
BRKR
|
46.4 | $ 39.08 | -1.83 % | $ 5.82 K | ||
|
GenMark Diagnostics, Inc.
GNMK
|
81.3 | - | - | $ 1.77 B | ||
|
Conformis
CFMS
|
50.4 | - | - | $ 16.4 M | ||
|
Lianluo Smart Limited
LLIT
|
10.5 | - | 24.59 % | $ 44.8 M | ||
|
Cardiovascular Systems
CSII
|
81.8 | - | 0.15 % | $ 844 M | ||
|
Cutera
CUTR
|
57.2 | - | -10.19 % | $ 1.99 M | ||
|
Obalon Therapeutics, Inc.
OBLN
|
224 | - | -5.86 % | $ 30.6 M | ||
|
Acutus Medical
AFIB
|
92.7 | - | -26.83 % | $ 2.62 M | ||
|
Dynatronics Corporation
DYNT
|
52.2 | - | 14.99 % | $ 929 K | ||
|
Eargo
EAR
|
124 | - | - | $ 10.2 M | ||
|
Allied Healthcare Products
AHPI
|
23.1 | - | 3.58 % | $ 2.21 M | ||
|
Second Sight Medical Products
EYES
|
21 | - | -0.97 % | $ 54.4 M | ||
|
Cognyte Software Ltd.
CGNT
|
81.1 | $ 7.79 | 3.73 % | $ 559 M | ||
|
FONAR Corporation
FONR
|
16.6 | $ 18.49 | -0.38 % | $ 121 M | ||
|
AdaptHealth Corp.
AHCO
|
43.9 | $ 9.41 | -2.39 % | $ 1.27 B | ||
|
Apollo Endosurgery
APEN
|
63.6 | - | - | $ 475 M | ||
|
CONMED Corporation
CNMD
|
57.3 | $ 43.34 | -5.35 % | $ 1.35 B | ||
|
IRIDEX Corporation
IRIX
|
50.7 | $ 1.45 | 2.84 % | $ 23.4 M | ||
|
CryoLife, Inc.
CRY
|
41.1 | - | -4.14 % | $ 702 M | ||
|
IRadimed Corporation
IRMD
|
40.6 | $ 104.65 | 0.88 % | $ 1.33 B | ||
|
Avinger
AVGR
|
45.5 | - | -20.74 % | $ 369 K | ||
|
CHF Solutions, Inc.
CHFS
|
204 | - | 1.15 % | $ 34.5 M | ||
|
AxoGen
AXGN
|
34.4 | $ 29.78 | -2.84 % | $ 1.37 B | ||
|
Apyx Medical Corporation
APYX
|
52.8 | $ 3.18 | -3.05 % | $ 110 M | ||
|
Axonics Modulation Technologies
AXNX
|
40.1 | - | - | $ 3.31 B | ||
|
Itamar Medical Ltd.
ITMR
|
131 | - | 0.03 % | $ 1.58 B | ||
|
Accuray Incorporated
ARAY
|
49.2 | $ 0.52 | -5.19 % | $ 53.4 M | ||
|
Misonix, Inc.
MSON
|
83.1 | - | - | $ 462 M | ||
|
Pulmonx Corporation
LUNG
|
44.6 | $ 1.53 | - | $ 59.8 M | ||
|
Neovasc
NVCN
|
48.6 | - | - | $ 111 M | ||
|
Medtronic PLC
MDT
|
76.2 | $ 96.73 | -1.38 % | $ 124 B | ||
|
Cytosorbents Corporation
CTSO
|
125 | $ 0.79 | 5.78 % | $ 43 M | ||
|
Align Technology
ALGN
|
33.7 | $ 182.92 | -3.23 % | $ 13.7 B | ||
|
Intersect ENT, Inc.
XENT
|
72.8 | - | - | $ 955 M | ||
|
Inari Medical
NARI
|
58.2 | - | - | $ 4.23 B | ||
|
Butterfly Network
BFLY
|
51.3 | $ 3.73 | -3.37 % | $ 790 M | ||
|
BIOLASE
BIOL
|
66.7 | - | -13.19 % | $ 166 K | ||
|
EDAP TMS S.A.
EDAP
|
40.6 | $ 3.96 | -3.54 % | $ 148 M | ||
|
Abbott Laboratories
ABT
|
79.7 | $ 113.53 | -0.49 % | $ 198 B | ||
|
NuVasive
NUVA
|
19.8 | - | - | $ 2.07 B | ||
|
Nevro Corp.
NVRO
|
61.7 | - | - | $ 217 M | ||
|
Orthofix Medical
OFIX
|
76.3 | $ 13.02 | -2.62 % | $ 516 M | ||
|
Boston Scientific Corporation
BSX
|
61.7 | $ 73.88 | -3.07 % | $ 109 B | ||
|
PAVmed
PAVM
|
128 | $ 9.94 | -0.4 % | $ 71.9 M | ||
|
Penumbra
PEN
|
26.1 | $ 340.23 | -0.61 % | $ 13.2 B |